A new KRAS-targeted therapy shows promise in treating pancreatic cancer, with trial results presented at an annual medical meeting.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
New KRAS Targeted Therapy Shows Promise Against Pancreatic Cancer | Memorial Sloan Kettering Cancer Center
Previously Untreated Pancreatic Cancer Patients Trial Population
Memorial Sloan Kettering Cancer Center Institution
April 2026 Annual Meeting Results Presentation
KRAS-Targeted Therapy Treatment Type